Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT00687518
NA

Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy Volunteers

Sponsor: Rennes University Hospital

View on ClinicalTrials.gov

Summary

The aim of this study is to measure the variations of serum and urinary hepcidin levels following a single intravenous injection of erythropoietin in healthy volunteers. Hepcidin is a major regulator of iron homeostasis. It acts by binding on ferroportin, and limits cellular efflux of iron through enterocytes and macrophages. Anemia and hypoxia are known to modulate hepcidin synthesis. In these situations, erythropoietin synthesis is increased, so it can be postulated that erythropoietin could modulate hepcidin synthesis.

Key Details

Gender

MALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

14

Start Date

2008-02-07

Completion Date

2008-09-30

Last Updated

2026-06-12

Healthy Volunteers

Yes

Interventions

DRUG

Erythropoietin

Intravenous injection of 50 U/kg of erythropoietin

DRUG

Placebo

Intravenous injection of equivalent volume of saline serum

Locations (1)

Unité d'Investigation Clinique - Centre d'Investigation Clinique - Hôpital de Pontchaillou

Rennes, France